Evaluation of the usefulness of the Japanese version of self-administered ALSFRS-R in ALS patients
- Conditions
- Amyotrophic lateral sclesoris (ALS)ALS, ALSFRS-R, PRO
- Registration Number
- JPRN-jRCT1070230112
- Lead Sponsor
- Isobe Noriko
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
1. Patients diagnosed with amyotrophic lateral sclerosis
2. Patients who fully understand the research plan and are able to give their own consent
3. Patients aged 18 years or older at the time of obtaining informed consent
1. Patients who are unable to operate electronic terminals due to either cognitive decline, cognitive dysfunction, or visual impairment
2. Patients with fever
3. Patients with neurological or psychiatric complications other than amyotrophic lateral sclerosis
4. Patients who the investigator considers to be unsuitable as research subjects
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.